Coronavirus Covid 19 vaccine emergency use authorisation: (Reuters/Representational Photo)Covid-19 vaccine emergency use authorisation: The Ministry of Health and Family Welfare informed on Wednesday that the Subject Expert Committee (SEC) in Central Drugs Standard Control Organisation (CDSCO) held a meeting to consider the Emergency Use Authorisation (EUA) request of Pfizer, Serum Institute of India (SII) and Bharat Biotech Pvt Ltd.
The health ministry also informed that more time was requested on behalf of Pfizer.
#IndiaFightsCorona #Unite2FightCorona
The Subject Expert Committee (SEC) met today to consider the Emergency Use Authorization request from @pfizer @SerumInstIndia & @BharatBiotech and is scheduled to reconvene on 1st Jan 2021.https://t.co/bXrNWYJ4Ad pic.twitter.com/p6rRdztC4X
— Ministry of Health (@MoHFW_INDIA) December 30, 2020
Also, the additional data and information presented by the Serum Institute of India and Bharat Biotech Pvt Ltd was perused and analysed by SEC.
The analysis of the additional data and information is going on, the health ministry release further added.
The Subject Expert Committee will convene again on Friday – January 1, 2021, the health ministry further informed.
More details awaited.
Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, Check out latest IPO News, Best Performing IPOs, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.
Financial Express is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.
